Professional Documents
Culture Documents
View Journal
Journal of
Materials Chemistry B
Materials for biology and medicine
Accepted Manuscript
This article can be cited before page numbers have been issued, to do this please use: M. Di Luca, M.
Curcio, E. Valli, G. Cirillo, F. Voli, M. E. Butini, A. Farfalla, E. Pantuso, A. Leggio, F. P. Nicoletta, A. Tavanti, F.
Iemma and O. Vittorio, J. Mater. Chem. B, 2019, DOI: 10.1039/C9TB00871C.
Volume 4 Number 1 7 January 2016 Pages 1–178 This is an Accepted Manuscript, which has been through the
Royal Society of Chemistry peer review process and has been
Journal of accepted for publication.
Materials Chemistry B Accepted Manuscripts are published online shortly after
Materials for biology and medicine
www.rsc.org/MaterialsB
rsc.li/materials-b
Page 1 of 11 Please of
Journal doMaterials
not adjust marginsB
Chemistry
ARTICLE
A multi-functional composite to be employed as dressing material was prepared by combining hydrogel and microparticle
systems. For the synthesis of hydrogel counterpart, a free radical polymerization was carried out using a Gelatin-Curcumin
conjugate, previously obtained through immobilized laccase catalysis, and polyethylene glycol dimethacrylate as functional
element, plasticizer, and crosslinker. Hydrogel was found to possess high water affinity, biocompatibility, and ability to
Published on 10 June 2019. Downloaded on 6/11/2019 3:41:00 AM.
reduce the H2O2 induced oxidative stress on MRC-5 cells by 30%. The spherical microparticle system (mean diameter of 1.75
µm) was prepared by self-assembly of a Keratin-methacrylated polyethylene glycol-40 stearate derivative synthesized by a
free radical reaction. The final composite, prepared by absorption of microparticles on hydrogel system, was found to be
effective as support for enhanced cell growth (3.5 times). Furthermore, a reduction of methicillin-resistant Staphylococcus
aureus proliferation by 1 log10 CFU was reached taking advantage of the sustained release of the antimicrobial Quercetin.
Australia 2031.
extracellular matrix.33-36 Hydrogel support (HGC) was
f. 6School of Women’s and Children’s Health, Faculty of Medicine, UNSW Sydney, synthesized by covalent incorporation of a Gelatin-Curcumin
NSW, Australia 2052. bioconjugate (Gel-CUR) into an acrylic network to take
g. ARC Centre of Excellence for Convergent BioNano Science and Technology,
Australian Centre for NanoMedicine, UNSW Sydney, NSW, Australia 2052. advantage from the peculiar features of Gel and Curcumin
‡ Equal contribution. (CUR) in wound healing: gelatin-based hydrogels possess,
†Electronic Supplementary Information (ESI) available. See DOI:
10.1039/x0xx00000x.
indeed, biocompatibility, non-immunogenicity, and capability
to promote homeostasis and preserve epidermal growth factor where A0 and A1were the absorbance of Gel and Gel-Cur; 𝒏𝟎𝑵𝑯𝟐
View Article Online
from proteolysis,37-40 while CUR has been proven to facilitate and 𝑴𝑾𝑪𝑼𝑹 the amount of NH2 groups in Gel, and the
DOI: 10.1039/C9TB00871C
wound healing by quenching free radical species.41, 42 molecular weight of CUR, respectively.
Moreover, the microparticle counterpart consisted in self
assembling lipidized Keratin (l-Ker) microparticles loaded with
2 | J. Mater. Chem. B, 2019, 00, 1-3 This journal is © The Royal Society of Chemistry 20xx
weighed. The water content percentage (WR) was expressed Germany) and coating with gold to a thickness ofView
about
Article300 Å
Online
by the following Equation (4): using a sputter coater. DOI: 10.1039/C9TB00871C
𝑊𝑠 ― 𝑊𝑑
𝑊𝑅 = 𝑊𝑑 × 100 (4) 2.6. Evaluation of MRC-5 proliferation on composite materials
grown as a monolayer at 37 °C in 5% CO2, and then seeded into microparticle (PK) and hydrogel formulations (HGC and HG) at a
96-well plates (100 µL per well) at a predetermined density 20% (w/w) ratio, by involving Q solution in DMSO in either PK
(~20,000 cells) to achieve 90% confluency by the endpoint of preparation or hydrogel swelling. The final DMSO concentration
the assay. was 10% vol/vol in all cases. Furthermore, when HGC and HG
For the cytotoxicity determinations, HGC and HG were were used, samples were finally dried to constant weight under
pulverized, suspended in DMEM + FCS 10% in a concentration vacuum. Loaded samples were coded Q@PK, Q@HGC, Q@HG,
range 0 – 5.0 mg mL-1 and incubated with MRC-5 cells. Q@PKHGC, and Q@PKHG.
For the antioxidant assay, pulverized HGC and HG (20 mg mL-1) The release experiments were performed in phosphate
were incubated with H2O2 in PBS (2.0 mL, 20 mmol L-1) for 1.5 h buffered saline (10-3 mol L-1) at pH 7.4 by inserting loaded carrier
in the dark at room temperature. Then, tubes were centrifuged in PBS (1.5 mL) into a dialysis bag (MWCO: 12,000-14,000 Da),
at 1500 rpm for 5 minutes and the supernatant used for cell and dialyzed against fresh DMSO solution in PBS (13.5 mL, 10%
treatments. vol/vol). At suitable time intervals, the amount of Q in the
Cell viability was determined after incubation at 37 °C, 5% CO2 release media was determined by UV-Vis at 373 nm.57
for 72 (cytotoxicity) or 4 (antioxidant assay) hours by measuring
resazurin reduction (excitation 530 nm, emission 590 nm) on a
Versamax microplate reader (Molecular Devices, Sunnyvale, CA, 2.8. Determination of antimicrobial activity
USA).52 2.8.1. Storage and culture of bacterial strain and antimicrobial
All chemicals were from Merck/Sigma Aldrich, Germany. agent. The bacterial stock of methicillin-resistant
Staphylococcus aureus (MRSA) ATCC 43300 was maintained in
cryovial bead preservation systems (Microbank; PRO-LAB
2.5. Preparation of microparticle and composite system DIAGNOSTICS, Richmond Hill, ON, Canada) at -80 °C. Bacterial
Microparticle system (PK) were prepared by the method strain was cultivated on Trypticase Soy Agar (TSA) (VWR
previously described for the preparation of β-casein micelles Chemicals, Leuven, Belgium) for 18 h at 37 °C. Inoculum size was
with slight modifications.53 Briefly, lipidized Keratin derivative prepared according to a McFarland standard turbidity of 0.5 (λ
(5.0 mg), synthesized according to a procedure published = 565 ± 15 nm) and determined by Colony Forming Unit (CFU)
elsewhere,54 were added to 2.45 mL PBS solution (10-3 M, pH counting. A stock solution of 1.5 mg mL-1 Q (Merck/Sigma
7.4), and then 50 µL DMSO were added with a final stirring at Aldrich, Germany) in 50% DMSO was freshly prepared before
room temperature for 3 h. Microparticles were employed each experiment.
without further purification because the amount of DMSO (2.0
% vol/vol) is not harmful to cells.55
The composite systems PKHGC and PKHG were prepared by 2.8.2. Antibacterial activity of free quercetin. The minimal
allowing HGC and HG (5.0 mg) to swell in 0.25 mL of PK prepared inhibiting concentration (MIC) of Q against planktonic MRSA
as above reported. was evaluated using broth microdilution following the CLSI
SEM images were recorded on NOVA NanoSEM 200 guidelines.58 Briefly, a standard inoculum of 1-5 × 105 CFUs mL-
1 was prepared in cation adjusted Müller Hinton Broth (CAMHB)
(ThermoFisher Scientific, Hillsboro, OR, USA) with an
acceleration voltage of 10 kV after depositing samples onto self- (Becton, Dickinson and Company, Le Pont de Claix, France) and
adhesive conducting carbon tape (Plano GmbH, Wetzlar, treated with two-fold serial dilutions of Q. Next, microdilution
tubes were incubated at 37 °C for 18 h. The MIC was defined as
This journal is © The Royal Society of Chemistry 20xx J. Mater. Chem. B, 2019, 00, 1-3 | 3
the lowest concentration of antimicrobial that completely PKHG, Q@PKHGC, and Q@PKHG) were added toVieweach tube
Article Online
inhibited the growth of the MRSA strain, as detected by unaided containing bacteria and then incubatedDOI:at 37 °C for 24 h. A
10.1039/C9TB00871C
eye. To evaluate the bactericidal activity of Q, samples showing positive control consisting of untreated bacteria (no hydrogel)
no turbidity from the previous experiment were plated for was included as growth control, as well as gels incubated in
colony counting after, 18 h-incubation at 37°C (plating sterile CAMHB and sterile CAMHB alone as negative controls.
4 | J. Mater. Chem. B, 2019, 00, 1-3 This journal is © The Royal Society of Chemistry 20xx
amino groups) in the side chain of the Gel (Fig. 1A).60-62 The use of
immobilized laccase was previously successfully exploited for the
derivatization of polysaccharide and protein materials with In detail, PEG40STMA was prepared via trans-esterification of PEG40ST
polyphenols species,63-66 with the advantages to address the with methacrylic anhydride (MA) using pyridine as a catalyst, and
requirements of a green environment (e.g. absence of any trace of then reacted with Ker thiol groups preliminarily activated by S2O8−
toxicity) and obtain high functionalization degree and purity of the radicals (Fig. 1B). This approach allowed the preparation of l-Ker with
final bioconjugates.67-69 The conjugation between Cur and Gel was a substitution degree of 27% and a critical aggregation concentration
proved by the presence of the characteristic CUR signals in the (CAC) of 10 µg mL-1, as per Ellman’s test and Pyrene fluorescence
aromatic resonance area of the Gel-Cur 1H-NMR spectra (Fig. 2). assay, respectively.54
Furthermore, the Uv-Vis spectra showed a shift of the Cur absorption
3.2. Synthesis and characterization of hydrogel systems
peak from 466 to 404 nm upon conjugation (Fig. S1).
Since the conjugation reaction mainly involved the NH2 groups of Gel, As reported in literature, gelatin gels possess low stability, and thus
their determination in Gel vs Gel-Cur by TNBS assay was used to different strategies have been developed to improve the thermal and
calculate the amount of linked Cur, obtaining a value of 79 mg per g mechanical properties of gelatin-based polymer networks.70-72 We
of conjugate. Finally, the determination of the trolox equivalent previously reported on the possibility to covalently incorporate
antioxidant capacity (TEAC) by testing the ABTS quenching activity, 51 gelatin into acrylate hydrogels via free radical polymerization, using
clearly proved that the conjugation procedure did not affect the AAm as plasticizing co-monomer and PEGDMA as crosslinking agent,
antioxidant power, with TEAC values being 2.43 ± 0.49 and 3.30 ± obtaining materials with high water affinity (WR of around 250 %)
0.48 for free and conjugated Cur, respectively (p>0.05). proposed for healing applications.59, 73 Here, following the same
l-Ker was prepared by conjugation of hydrolyzed Ker with approach, Gel-Cur was successfully employed for the preparation of
PEG40STMA via a free radical reaction, as previously reported for the HGC (0.8 mm thickness) (Fig. 1C), optimizing the reagent ratio in order
preparation of self-assembling delivery vehicles for targeted release to maximize the water affinity while avoiding hydrogel breakage
of lipophilic anticancer drugs.54 upon drying.
Fig. 3. SEM images of HGC (A); PK (B) and PKHGC (C). Calibration bars denote 20 µm.
This journal is © The Royal Society of Chemistry 20xx J. Mater. Chem. B, 2019, 00, 1-3 | 5
As a control sample, HG was synthesized by replacing Gel-Cur with 3.3. Synthesis and characterization of Keratin microparticles
native Gel. HGC was characterized by a rough surface, as per SEM We explored the suitability of l-Ker for the preparation of the
investigation (Fig. 3A), and increased swelling profile over time, with microparticle system (PK- Fig. 1D) able to release the antimicrobial
Published on 10 June 2019. Downloaded on 6/11/2019 3:41:00 AM.
a maximum WR of 990% after 24 h (Fig. S2). The higher water affinity agent Q, by taking advantages from the ability to both encapsulate
recorded for HGC compared to HG matrix (maximum WR of 710%) can lipophilic agents and to promote cell proliferation.54 Due to its
be attributed to the interference of Cur into the polymerization amphiphilic behavior, l-Ker self-assemblies in water media with the
mechanism: Cur moieties, indeed, acted as quenching agent for the hydrophobic blocks (mainly stearyl residues) oriented toward the
growing polymer chains, resulting in a reduced crosslinking degree.74 inner core and the hydrophilic portions of Ker and PEG towards the
This finding was further supported by the determination of ultimate external environment. Morphological analysis and measurement of
tensile strength, which was reduced by 25% compared to the sample particle size distribution, performed by SEM analysis (Fig. 3B),
prepared in the absence of Cur (22.5 and 30.0 MPa for HGC and HG, showed spherical microparticles with a smoot and uniform surface
respectively). The key requirement of absence of cytotoxicity was (see inset of Fig. 3B) and a mean diameter of approximately 1.75 µm.
assessed by checking the viability of Human foetal lung fibroblasts Q@PK was obtained by performing the self-assembly process in the
MRC-5, a widely recognized human skin equivalent for in vitro assays, presence of a Q solution in DMSO (saturated solution, 30 mg mL-1), a
well matching with the EU regulations encouraging replacement of methodology widely reported in the literature for the encapsulation
animal models (EU Directive 2010/63/EU).75, 76 Such cells, by virtue of different lipophilic drugs in protein self-assembling systems.82, 83
of their specific metabolic features and high sensibility to almost any
types of chemical species, were found to be useful for the
classification and risk assessment studies of chemicals and 3.4. Synthesis and characterization of assembled devices
biomedical devices.77-80 After incubation of HGC and HG in HGC and PK were assembled to form the final PKHGC composite (Fig.
concentrations ranged from 1.25 to 5.0 mg mL-1 (corresponding to 1E), with SEM analysis showing PK embedded into hydrogel matrix as
the highest amount of samples to be suspended in cell culture media) a confirmation of the effective absorption onto HGC without
for 72 h, viability values higher than 97 % were recorded in all modification of either shape or size patterns (Fig. 3C). The ability to
conditions (Fig. S3), proving the high biocompatibility of the induce cell proliferation plays a key role in assessing the performance
proposed hydrogel systems. of a functional dressing device, thus facilitating the healing
In consideration of the recorded antioxidant performance of Gel-Cur process.84, 85 In our experiments, PKHGC was found to promote cell
conjugate, we tested the ability of HGC formulations to protect viability, with the number of MRC-5 cells increasing by 3.5 times
wounds from oxidative stress produced by H2O2, which is well known compared to the control after 72 h incubation. PK acted as the
to cause high mortality of MRC-5 cells.81. functional element for cell proliferation, since un-assembled HGC did
At first, the maintenance of Gel-Cur antioxidant properties was not showed any effect on cell viability (Fig. S3).
confirmed by determining the HGC TEAC value, which was found to Furthermore, the incubation of PKHGC with cells transfected with a
be 1.48 ± 0.48 with HG showing no ability to quench ABTS radical; and Green Fluorescent Protein (GFP) has been used as noninvasive
then the MRC-5 viability upon exposure to H2O2 was assessed. approach for assessing the cells activation in a healing process.86, 87
For the latter determination, MRC-5 viability was assessed after In our case, Neuroblastoma KELLY-GFP cells were used because they
treatment with H2O2 previously incubated with either HGC or HG, are easy to transfect88 and possessed proved ability to fast migrate
proving that HGC was able to reduce the oxidative stress by 30% (H2O2 in a wound-healing assay.89 Inverted fluorescence microscope
equivalent IC50 value increased from 186 to 246 µmol L-1). As analyses revealed the presence of fluorescent cells on the non-
expected, no interference was detected when HG was used (Fig. 4). fluorescent hydrogel support, confirming the ability of growing GFP
cells to colonize the device (Fig. 5).
6 | J. Mater. Chem. B, 2019, 00, 1-3 This journal is © The Royal Society of Chemistry 20xx
𝑭𝒎𝒂𝒙
𝒕𝟏𝟏/𝟐 = 𝒌𝑹 𝒍𝒏𝟐 (8)
𝛼
𝑡21/2 = 2𝑘𝑅ln (3 ― 2𝐹𝑚𝑎𝑥) (9)
𝑀𝑡 𝐹𝑚𝑎𝑥(𝑒
( ) ― 1)
2
𝛼
𝑡 addition, Q is contextually less toxic and provides fewer side effects
= (7) compared to that of conventional antimicrobial agents.46
𝑀0 𝑘𝑅
1 ― 2𝐹𝑚𝑎𝑥 +𝑒
( ) 2
𝛼
𝑡
𝑴𝒕 𝑭𝒎𝒂𝒙(𝒆
𝟐 ( ) ― 𝟏)
𝜶
𝒕 Fmax 0.98 0.99 0.85 0.82 0.84
= Α 49.0 99.0 5.67 4.56 5.25
𝑴𝟎 𝒌𝑹
𝟏 ― 𝟐𝑭𝒎𝒂𝒙 + 𝒆
( ) 𝟐
𝜶
𝒕 kR (10-2) 3.0 4.5 0.28 0.14 0.21
𝒕𝟐𝟏/𝟐 (min) 32 22 265 500 347
This journal is © The Royal Society of Chemistry 20xx J. Mater. Chem. B, 2019, 00, 1-3 | 7
Acknowledgements
This work was supported by University of Calabria (Italy) funds
(ex 60%).
References
Fig. 7. Antibacterial activity of different formulations releasing quercetin Surfaces B: Biointerfaces, 2018, 172, 233-243.
against planktonic MRSA ATCC 43300 in CAMH/DMSO (10% vol/vol). T0, initial
2. A. J. Singer and R. A. F. Clark, New England Journal of
bacterial inoculum at time 0; GCtrl: bacterial growth control after 24h
incubation. An overall p-value less than 0.05 was accepted as significant. Medicine, 1999, 341, 738-746.
Adjusted p-values are indicated for individual comparisons as * p < 0.05, ** p 3. P. Picone, M. A. Sabatino, A. Ajovalasit, D. Giacomazza, C.
< 0.005. Error bars represent standard error of the mean. Dispenza and M. Di Carlo, International Journal of
Biological Macromolecules, 2019, 121, 784-795.
Q as free molecule exhibited a MIC of 64 µg mL-1 when tested against 4. G. C. Gurtner, S. Werner, Y. Barrandon and M. T. Longaker,
MRSA, whereas a bactericidal activity was achieved with Nature, 2008, 453, 314-321.
5. E. R. Zielins, D. A. Atashroo, Z. N. Maan, D. Duscher, G. G.
concentrations higher than 128 µg mL-1 (MBC). The antimicrobial
Walmsley, O. Marecic, M. Hu, K. Senarath-Yapa, A.
activity of Q@PKHGC was determined by plating and colony counting
McArdle, R. Tevlin, T. Wearda, K. J. Paik, C. Duldulao, W. X.
after incubation of the biomaterials in inoculated medium (Fig. 7). Hong, G. C. Gurtner and M. T. Longaker, Regenerative
The number of CFUs mL-1 of untreated bacteria in CAMHB/10% Medicine, 2014, 9, 817-830.
DMSO increased about more than 3log10 from the initial inoculum 6. X. Wang, J. Chang and C. Wu, Applied Materials Today,
after 24h incubation, thus excluding any toxic effect of the 2018, 11, 308-319.
organosulfur compound at that specific concentration (10% DMSO). 7. H. Liu, C. Wang, C. Li, Y. Qin, Z. Wang, F. Yang, Z. Li and J.
When MRSA bacterial cells were incubated with either Q@PKHGC or Wang, RSC Advances, 2018, 8, 7533-7549.
Q@PKHG, a reduction of 1 log10 CFU was observed in comparison to 8. S. Das and A. B. Baker, Frontiers in Bioengineering and
the CFU obtained in the presence of unloaded hydrogel or hydrogel Biotechnology, 2016, 4.
with Cur alone, confirming a partial inhibition of the bacterial growth 9. Q. Li, F. Lu, G. Zhou, K. Yu, B. Lu, Y. Xiao, F. Dai, D. Wu and
G. Lan, Biomacromolecules, 2017, 18, 3766-3775.
due to the release of Q.
10. P. T. S. Kumar, S. Abhilash, K. Manzoor, S. V. Nair, H.
Tamura and R. Jayakumar, Carbohydrate Polymers, 2010,
80, 761-767.
Conclusions 11. H. Ye, J. Cheng and K. Yu, International Journal of Biological
With the aim to fabricate a multi-functional composite material Macromolecules, 2019, 121, 633-642.
to be employed in wound dressing applications, we combined 12. H. S. Kim, X. Sun, J. H. Lee, H. W. Kim, X. Fu and K. W. Leong,
the features of functional hydrogel and spherical microparticle Advanced Drug Delivery Reviews, 2019.
systems, each showing peculiar features. Hydrogel counterpart 13. M. G. Arafa, R. F. El-Kased and M. M. Elmazar, Scientific
Reports, 2018, 8.
was designed to address the requirements of moisture and
14. M. A. Mofazzal Jahromi, P. Sahandi Zangabad, S. M.
ability to protect from ROS toxicity acting, at the same time, as
Moosavi Basri, K. Sahandi Zangabad, A. Ghamarypour, A. R.
support for cell growth. Microparticle system was intended to Aref, M. Karimi and M. R. Hamblin, Advanced Drug Delivery
promote cell proliferation and control the release of a suitable Reviews, 2018, 123, 33-64.
antimicrobial agent, thus preserving the healing site from 15. S. Moritz, C. Wiegand, F. Wesarg, N. Hessler, F. A. Müller,
microbial infections. For the first purpose, a Gelatin-Curcumin D. Kralisch, U. C. Hipler and D. Fischer, International Journal
conjugate was inserted within an acrylate hydrogel, with high of Pharmaceutics, 2014, 471, 45-55.
antioxidant properties observed, while a lipidized Keratin undergoing 16. T. Wang, Y. Zheng, Y. Shen, Y. Shi, F. Li, C. Su and L. Zhao,
a self-assembly process was prepared to fabricate the microparticle Artificial Cells, Nanomedicine and Biotechnology, 2018, 46,
system able to encapsulate the bioactive agent Quercetin. The 138-149.
suitability of the final composite device in wound healing was tested 17. S. Kumar, P. K. Lakshmi, C. Sahi and R. S. Pawar, Journal of
Ethnopharmacology, 2019, 235, 279-292.
8 | J. Mater. Chem. B, 2019, 00, 1-3 This journal is © The Royal Society of Chemistry 20xx
18. N. Mayet, Y. E. Choonara, P. Kumar, L. K. Tomar, C. Tyagi, L. 41. M. Khamrai, S. L. Banerjee, S. Paul, S. Samanta and P. P.
View Article Online
C. Du Toit and V. Pillay, Journal of Pharmaceutical Sciences, Kundu, International Journal of Biological Macromolecules,
DOI: 10.1039/C9TB00871C
2014, 103, 2211-2230. 2019, 122, 940-953.
19. Y. Loo, Y. C. Wong, E. Z. Cai, C. H. Ang, A. Raju, A. 42. C. Mohanty and S. K. Sahoo, Drug Discovery Today, 2017,
Lakshmanan, A. G. Koh, H. J. Zhou, T. C. Lim, S. M. 22, 1582-1592.
Moochhala and C. A. E. Hauser, Biomaterials, 2014, 35, 43. J. Fan, M. Y. Yu, T. D. Lei, Y. H. Wang, F. Y. Cao, X. Qin and
R. K. Goel, BioMed Research International, 2013, 2013. 48. O. Vittorio, M. Cojoc, M. Curcio, U. G. Spizzirri, S. Hampel,
26. E. V. Mikhal'chik, M. V. Anurov, S. M. Titkova, E. A. F. P. Nicoletta, F. Iemma, A. Dubrovska, M. Kavallaris and
Miroshnikova, E. V. Lukasheva, I. B. Deeva, G. A. G. Cirillo, Macromolecular Chemistry and Physics, 2016,
Ibragimova and L. G. Korkina, Bulletin of Experimental 217, 1488-1492.
Biology and Medicine, 2006, 142, 667-669. 49. S. Hadi, A. N. Artanti, Y. Rinanto and D. S. C. Wahyuni, 2018.
27. D. Poranki, W. Whitener, S. Howse, T. Mesen, E. Howse, J. 50. D. R. Garcia and N. Lavignac, Polymer Chemistry, 2016, 7,
Burnell, O. Greengauz-Roberts, J. Molnar and M. Van Dyke, 7223-7229.
Journal of Biomaterials Applications, 2014, 29, 26-35. 51. M. J. T. J. Arts, J. Sebastiaan Dallinga, H. P. Voss, G. R. M.
28. M. E. Smithmyer, L. A. Sawicki and A. M. Kloxin, M. Haenen and A. Bast, Food Chemistry, 2004, 88, 567-570.
Biomaterials Science, 2014, 2, 634-650. 52. A. Parmar, G. Pascali, F. Voli, L. Lerra, E. Yee, A. Ahmed-Cox,
29. S. Kurhade, M. Momin, P. Khanekar and S. Mhatre, K. Kimpton, G. Cirillo, A. Arthur, D. Zahra, G. Rahardjo, G. J.
International Journal of Drug Delivery, 2013, 5, 353-361. Liu, N. Lengkeek, F. Saletta, A. Charil, M. Kavallaris and O.
30. C. Dannert, B. T. Stokke and R. S. Dias, Polymers, 2019, 11. Vittorio, Theranostics, 2018, 8, 5645-5659.
31. X. Hu, Y. Wang, L. Zhang, M. Xu, J. Zhang and W. Dong, 53. R. N. Parker, K. L. Roth, C. Kim, J. P. McCord, M. E. Van Dyke
International Journal of Biological Macromolecules, 2018, and T. Z. Grove, Biopolymers, 2017, 107.
107, 1811-1820. 54. M. Curcio, B. Blanco-Fernandez, L. Diaz-Gomez, A.
32. H. Chen, X. Xing, H. Tan, Y. Jia, T. Zhou, Y. Chen, Z. Ling and Concheiro and C. Alvarez-Lorenzo, Bioconjugate Chemistry,
X. Hu, Materials Science and Engineering C, 2017, 70, 287- 2015, 26, 1900-1907.
295. 55. A. Shapira, Y. G. Assaraf and Y. D. Livney, Nanomedicine:
33. N. Eslahi, M. Abdorahim and A. Simchi, Nanotechnology, Biology, and Medicine, 2010, 6, 119-126.
Biomacromolecules, 2016, 17, 3441-3463. 56. O. Vittorio, M. Brandl, G. Cirillo, K. Kimpton, E. Hinde, K.
34. S. S. D. Kumar, N. K. Rajendran, N. N. Houreld and H. Gaus, E. Yee, N. Kumar, H. Duong, C. Fleming, M. Haber, M.
Abrahamse, International Journal of Biological Norris, C. Boyer and M. Kavallaris, Oncotarget, 2016, 7,
Macromolecules, 2018, 115, 165-175. 47479-47493.
35. T. Ponrasu, P. K. Veerasubramanian, R. Kannan, S. Gopika, 57. M. Islami, A. Zarrabi, S. Tada, M. Kawamoto, T. Isoshima
L. Suguna and V. Muthuvijayan, RSC Advances, 2018, 8, and Y. Ito, International Journal of Nanomedicine, 2018, 13,
2305-2314. 6059-6071.
36. T. Thanikachalam, T. K. R. Selvaraj, M. Ayyappan and G. 58. CLSI, CLSI document M07-A9, 2012.
Arumugam, Journal of Tissue Engineering and 59. M. di Luca, O. Vittorio, G. Cirillo, M. Curcio, M. Czuban, F.
Regenerative Medicine, 2019, 13, 174-178. Voli, A. Farfalla, S. Hampel, F. P. Nicoletta and F. Iemma,
37. S. C. Notodihardjo, N. Morimoto, N. Kakudo, T. Mitsui, T. International Journal of Pharmaceutics, 2018, 546, 50-60.
M. Le, Y. Tabata and K. Kusumoto, Journal of Surgical 60. V. Madhavi and S. S. Lele, BioResources, 2009, 4, 1694-
Research, 2019, 234, 190-201. 1717.
38. J. Tavakoli, Journal of the Mechanical Behavior of 61. C. Silva, T. Matamá, S. Kim, J. Padrão, E. Nugroho Prasetyo,
Biomedical Materials, 2017, 65, 373-382. T. Kudanga, G. S. Nyanhongo, G. M. Guebitz, M. Casal and
39. A. Tanaka, T. Nagate and H. Matsuda, Journal of Veterinary A. Cavaco-Paulo, Reactive and Functional Polymers, 2011,
Medical Science, 2005, 67, 909-913. 71, 713-720.
40. C. Wang, F. Zhu, Y. Cui, H. Ren, Y. Xie, A. Li, L. Ji, X. Qu, D. 62. S. Sampaio, P. Taddei, P. Monti, J. Buchert and G. Freddi,
Qiu and Z. Yang, Journal of Materials Science: Materials in Journal of Biotechnology, 2005, 116, 21-33.
Medicine, 2017, 28. 63. E. M. H. Yee, M. B. Brandl, E. Pasquier, G. Cirillo, K.
This journal is © The Royal Society of Chemistry 20xx J. Mater. Chem. B, 2019, 00, 1-3 | 9
Kimpton, M. Kavallaris, N. Kumar and O. Vittorio, Scientific 87. M. H. Kim, W. Liu, D. L. Borjesson, F. R. E. Curry, L. S. Miller,
View Article Online
Reports, 2017, 7. A. L. Cheung, F. T. Liu, R. R. IsseroffDOI:
and10.1039/C9TB00871C
S. I. Simon, Journal
64. K. Li, G. Guan, J. Zhu, H. Wu and Q. Sun, Food Control, 2019, of Investigative Dermatology, 2008, 128, 1812-1820.
96, 234-243. 88. J. Ham, C. Costa, R. Sano, T. L. Lochmann, E. M. Sennott, N.
65. M. Zheng, C. Zhang, Y. Zhou, Z. Lu, H. Zhao, X. Bie and F. Lu, U. Patel, A. Dastur, M. Gomez-Caraballo, K. Krytska, A. N.
Frontiers in Microbiology, 2018, 9. Hata, K. V. Floros, M. T. Hughes, C. T. Jakubik, D. A. R.
Klein and J. Malda, Macromolecular Bioscience, 2013, 13, 91. J. Zhou, D. Yao, Z. Qian, S. Hou, L. Li, A. T. A. Jenkins and Y.
551-561. Fan, Biomaterials, 2018, 161, 11-23.
72. M. A. Daniele, A. A. Adams, J. Naciri, S. H. North and F. S. 92. P. Pallavicini, C. R. Arciola, F. Bertoglio, S. Curtosi, G.
Ligler, Biomaterials, 2014, 35, 1845-1856. Dacarro, A. D'Agostino, F. Ferrari, D. Merli, C. Milanese, S.
73. G. Cirillo, M. Curcio, U. G. Spizzirri, O. Vittorio, P. Tucci, N. Rossi, A. Taglietti, M. Tenci and L. Visai, Journal of Colloid
Picci, F. Iemma, S. Hampel and F. P. Nicoletta, European and Interface Science, 2017, 498, 271-281.
Polymer Journal, 2017, 90, 1-12.
74. N. Killi, V. L. Paul and R. V. N. Gundloori, New Journal of
Chemistry, 2015, 39, 4464-4470.
75. C. M. A. Reijnders, A. Van Lier, S. Roffel, D. Kramer, R. J.
Scheper and S. Gibbs, Tissue Engineering - Part A, 2015, 21,
2448-2459.
76. O. Romero-Cerecero, A. Zamilpa-Álvarez, A. Ramos-Mora,
D. Alonso-Cortés, J. E. Jiménez-Ferrer, M. E. Huerta-Reyes
and J. Tortoriello, Planta Medica, 2011, 77, 979-983.
77. E. Pasquier, J. Street, C. Pouchy, M. Carre, A. J. Gifford, J.
Murray, M. D. Norris, T. Trahair, N. Andre and M. Kavallaris,
British Journal of Cancer, 2013, 108, 2485-2494.
78. S. H. Mathes, H. Ruffner and U. Graf-Hausner, Advanced
Drug Delivery Reviews, 2014, 69-70, 81-102.
79. D. Nassar, E. Letavernier, L. Baud, S. Aractingi and K.
Khosrotehrani, PLoS ONE, 2012, 7.
80. M. A. Mariggiò, A. Cassano, A. Vinella, A. Vincenti, R.
Fumarulo, L. Lo Muzio, E. Maiorano, D. Ribatti and G. Favia,
International Journal of Immunopathology and
Pharmacology, 2009, 22, 485-492.
81. B. Kong, X. Peng, Y. L. Xiong and X. Zhao, Food Chemistry,
2012, 135, 540-547.
82. X. Hu, X. Wang, J. Rnjak, A. S. Weiss and D. L. Kaplan,
Biomaterials, 2010, 31, 8121-8131.
83. B. An, D. L. Kaplan and B. Brodsky, Frontiers in Chemistry,
2014, 2.
84. P. Kamalathevan, P. S. Ooi and Y. L. Loo, Advances in Skin
and Wound Care, 2018, 31, 565-573.
85. V. V. Hiew, S. F. B. Simat and P. L. Teoh, Stem Cell Reviews
and Reports, 2018, 14, 43-57.
86. S. T. Fraser, A. K. Hadjantonakis, K. E. Sahr, S. Willey, O. G.
Kelly, E. A. V. Jones, M. E. Dickinson and M. H. Baron,
Genesis, 2005, 42, 162-171.
10 | J. Mater. Chem. B, 2019, 00, 1-3 This journal is © The Royal Society of Chemistry 20xx
n
Cell�
al�Activity
Antibacteri
Proliferatio
Drug��
Release
Sustained�